Glioma patient-reported outcome assessment in clinical care

Affiliations

¹ Centre Hospitalier Regional Universitaire de Lille, Department of Neurosurgery and Neuro-oncology, Neurosurgery Service, F-59000 Lille, France; Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland. Electronic address: constantin.tuleasca@chuv.ch.
² Weill Cornell Medicine, Department of Radiation Oncology, New York-Presbyterian Hospital, New York, NY, USA.
³ University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland; University of Lille, Inserm, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, Lille, France.
⁴ Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, Switzerland.
⁵ Centre Hospitalier Regional Universitaire de Lille, Department of Neurosurgery and Neuro-oncology, Neurosurgery Service, F-59000 Lille, France.
⁶ Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
⁷ Centre Hospitalier Regional Universitaire de Lille, Department of Neurosurgery and Neuro-oncology, Neurosurgery Service, F-59000 Lille, France; University of Lille, Inserm, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, Lille, France.

Comment

Constantin Tuleasca et al. Lancet Oncol. 2020 May.

. 2020 May;21(5):e230.

doi: 10.1016/S1470-2045(20)30141-8.

¹ Centre Hospitalier Regional Universitaire de Lille, Department of Neurosurgery and Neuro-oncology, Neurosurgery Service, F-59000 Lille, France; Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland. Electronic address: constantin.tuleasca@chuv.ch.
² Weill Cornell Medicine, Department of Radiation Oncology, New York-Presbyterian Hospital, New York, NY, USA.
³ University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland; University of Lille, Inserm, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, Lille, France.
⁴ Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, Switzerland.
⁵ Centre Hospitalier Regional Universitaire de Lille, Department of Neurosurgery and Neuro-oncology, Neurosurgery Service, F-59000 Lille, France.
⁶ Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
⁷ Centre Hospitalier Regional Universitaire de Lille, Department of Neurosurgery and Neuro-oncology, Neurosurgery Service, F-59000 Lille, France; University of Lille, Inserm, CHU Lille, U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology, Lille, France.

No abstract available

Comment in

Glioma patient-reported outcome assessment in clinical care - Authors' reply.
Armstrong TS, Chang SM, Jenkinson D, Kluetz P, Taphoorn MJB. Armstrong TS, et al. Lancet Oncol. 2020 May;21(5):e231. doi: 10.1016/S1470-2045(20)30241-2. Lancet Oncol. 2020. PMID: 32359496 No abstract available.

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, Espinasse C, Gilbert MR, Jenkinson D, Kluetz P, Mendoza T, Rubinstein L, Sul J, Weller M, Wen PY, van den Bent MJ, Taphoorn MJB. Armstrong TS, et al. Lancet Oncol. 2020 Feb;21(2):e97-e103. doi: 10.1016/S1470-2045(19)30796-X. Lancet Oncol. 2020. PMID: 32007210 Review.